DFW Healthcare Brief: $1.1 Billion Acquisition by Tenet and Medical City Leader Appointed to AHA Regional Board

Medical City Plano CEO Jyric Sims to serve as the American Hospital Association’s Regional Policy Board 7 Chief Executive Officer and will begin his term this month. The AHA represents hospitals and health care networks in advocacy issues, and regional councils meet throughout the year to discuss policy issues and treatment alternatives. “I am honored to help advance and defend high-quality health care as a delegate to this remarkable American Hospital Association Board of Directors,” Sims said in a statement. “Collaborating with other hospital systems and healthcare leaders enables us to elevate excellent, accessible and affordable healthcare for all.”

Tenet Healthcare Corp. and its subsidiary United Surgical Partners International have acquired SurgCenter Development, a company that partners with physicians to create physician-owned and operated day surgery centers. The acquisition included 86 day surgery centers and other support services for $1.1 billion. The USPI is proposing to acquire a portion of the physician owner equity of the ASCs for $250 million, which is an ongoing process.

Decades of research at UT Southwestern Medical Center have resulted in a first-of-its-kind immunomodulatory drug that has received Food and Drug Administration approval. The treatment is for myasthenia gravis, an autoimmune disease characterized by debilitating muscle weakness. Former UTSW immunology professor Dr. E. Sally Ward conducted work between 1990 and 2015 to find the treatment, which was exclusively licensed by ArgenX, a Belgium-based biotech company. Clinical trials have shown that 68% of patients with the most common form of myasthenia gravis responded to medication.

SUS Oral Surgery Management Specialty Management Services Company Established New Partnership Oral and Maxillofacial Surgery of Northwest Florida, his second collaboration in Florida. In addition,Dr. Maxwell D. Finn, of Oral Surgery Associates of North Texas, will be stepping down from the company’s board of directors. He will be replaced by Dr. Vincent J. Perciaccante of South Oral & Maxillofacial Surgery, near Atlanta, Georgia.


Will is the editor of CEO magazine and editor of D CEO Healthcare. He wrote about health care…

Comments are closed.